Natural androgens inhibit male atherosclerosis: A study in castrated, cholesterol-fed rabbits

Circulation Research

Volumn 84, Issue 7, 1999, Pages 813-819

  Alexandersen, Peter ^a   Haarbo, Jens ^a   Byrjalsen, Inger ^a   Lawaetz, Henrik ^a   Christiansen, Claus ^a  

^a CENTER FOR CLINICAL AND BASIC RESEARCH   (Denmark)

Author keywords

Androgen; Atherosclerosis; Rabbit; Testosterone

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CHOLESTEROL; ESTROGEN RECEPTOR; LIPID; LIPOPROTEIN; PRASTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

ANIMAL MODEL; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CASTRATION; CONTROLLED STUDY; HORMONE ACTION; INTRAMUSCULAR DRUG ADMINISTRATION; LIPID BLOOD LEVEL; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

EID: 0033574718     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.84.7.813     Document Type: Article

References (50)

1. US Department of Health, Education and Welfare. Vital Statistics of the United States, 1976. II. Mortality, Part A. Washington DC. US Department of Health, Education and Welfare; 1980. Publication No. 80-1101.
2. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes in mortality results. JAMA. 1982;248:1465-1470.
3. Castelli WP. Lipids, risk factors and ischemic heart disease. Atherosclerosis. 1996;124(suppl):S1-S9.
4. Foreman MD. Cardiovascular disease: a men's health hazard. Nurs Clin North Am. 1986;21:65-73.
5. Kalin MF, Zumoff B. Sex hormones and coronary disease: a review of the clinical studies. Steroids. 1990;55:30-52.
6. Bagatell CJ, Bremner WJ. Androgens on men: uses and abuses. N Engl J Med. 1996;334:707-714.
7. National Cholesterol Education Program. Highlights of the Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Bethesda, Md: National Institutes of Health; 1987. Report No. NIH-88-2926.
8. Study group, European Atherosclerosis Society. The recognition and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart J. 1988;9:571-600.
9. Barrett-Connor E, Khaw KT, Yen SSC. A prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease. N Engl J Med. 1986;315:1519-1524.
10. Barrett-Connor E, Khaw KT. Endogenous sex hormones and cardiovascular disease in men: a prospective population-based study. Circulation. 1988;78:539-545.
11. Yarnell JWG, Beswick AD, Sweetnam PM, Riad-Fahmy D. Endogenous sex hormones and ischemic heart disease in men. The Caerphilly Prospective Study. Arterioscler Thromb. 1993;13:517-520.
12. Phillips GB, Pinkernell BH, Jing TY. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb. 1994; 14:701-706.
13. Mitchell LE, Sprecher DL, Borecki IB, Rice T, Laskarzewski PM. Evidence for an association between dehydroepiandrosterone sulfate and non-fatal, premature myocardial infarction in males. Circulation. 1994; 89:89-93.
14. Marques-Vidal P, Sie P, Cambou J-P, Chap H, Perret B. Relationships of plasminogen activator inhibitor activity and lipoprotein (a) with insulin, testosterone, 17β-estradiol, and testosterone binding globulin in myocardial infarction patients and healthy controls. J Clin Endocrinol Metab. 1995;80:1794-1798.
15. Larsen BA, Nordestgaard BG, Stender S, Kjeldsen K. Effect of testosterone on atherogenesis in cholesterol-fed rabbits with similar plasma cholesterol levels. Atherosclerosis. 1993;99:79-86.
16. Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of dehydroepiandrosterone: a study in the hypercholesterolemic New Zealand white rabbit with aortic intimal injury. J Clin Invest. 1988;82:712-720.
17. Eich DM, Nestler JE, Johnson DE, Dworkin GH, Ko D, Wechsler AS, Hess ML. Inhibition of accelerated coronary atherosclerosis with dehydroepiandrosterone in the heterotopic rabbit model of cardiac transplantation. Circulation. 1993;8:261-269.
18. Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 1996;125:1-13.
19. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
20. Haarbo J, Svendsen OL, Christiansen C. Progestogens do not affect the aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. Circ Res. 1992;70:1198-1202.
21. Kaplan HM, Timmons EH. The Rabbit: A Model for the Principles of Mammalian Physiology and Surgery. New York, NY: Academic Press Inc; 1979:127-129.
22. Bjarnason NH, Haarbo J, Byrjalsen I, Kauffman RF, Christiansen C. Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits. Circulation. 1997;96:1964-1969.
23. Thorpe SM. Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays. Breast Cancer Res Treat. 1987;9: 175-189.
24. Thorpe SM, Lykkesfeldt AE, Vinterby A, Lonsdorfer M. Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies. Cancer Res. 1986;46:4251s-4255s.
25. Leake RE, Habib F. Steroid hormone receptors: assay and characterization. In: Green B, Leake RE, eds. Steroid Hormones: A Practical Approach. Oxford, United Kingdom: IRL Press; 1987:67-92.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
27. SAS Institute Inc. SAS/STAT: User's Guide Version 6. 4th ed. Cary, NC: SAS Institute Inc, 1989.
28. Phillips GB, Pinkernell BH, Jing TY. The association of hyperestrogenemia with coronary heart disease in men. Arterioscler Thromb. 1994; 14:701-706.
29. Jesse R, Nestler J, Eich D, Hess M. Dehydroepiandrosterone in vivo and in vitro inhibits platelet aggregation. J Am Coll Cardiol. 1991;17:376A. Abstract.
30. Arad Y, Badimon JJ, Badimon L, Hembree WC, Ginsberg HN. Dehydroepiandrosterone feeding prevents aortic fatty streak formation and cholesterol accumulation in cholesterol-fed rabbit. Arteriosclerosis. 1989;9:159-166.
31. Yue P, Chatterjee K, Beale C, Pool-Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91: 1154-1160.
32. Chou TM, Sudir K, Hutchison SJ, Ko E, Amidon TM, Collins P, Chatterjee K. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2414-2419.
33. Lin AL, Gonzalez R, Shain SA. Androgen directs apparent cytoplasmatic and nuclear distribution of rat cardiovascular androgen receptors. Arteriosclerosis. 1985;5:659-667.
34. Lin AL, Shain SA. Estrogen-mediated cytoplasmatic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis. 1985;5:668-677.
35. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye J-C. Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology. 1995;136:1523-1529.
36. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase expression in health and disease. Recent Prog Horm Res. 1997;52:185-213.
37. Bagatell CJ, Heiman JR, Matsumoto AM, Rivier JE, Bremner WJ. Metabolic and behavioral effect of high dose exogenous testosterone in healthy men. J Clin Endocrinol Metab. 1994;79:561-567.
38. Gutai J, LaPorte R, Kuller L, Dai W, Falvo-Gerad L, Caggiula A. Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol. 1981;48:897-902.
39. Khaw KT, Barrett-Connor E. Endogenous sex hormones, high density lipoprotein cholesterol, and other lipoprotein fractions in men. Arterioscler Thromb. 1991;11:489-494.
40. Ben-David M, Dikstein S, Bismuth G, Sulman FG. Anti-hypercholesterolemic effect of dehydroepiandrosterone in rats. Proc Soc Exp Biol Med. 1967;125:1136-1140.
41. Ellyin FM. The long term beneficial effect of low dose testosterone in the aging male. In: The Endocrine Society 77th Annual Meeting Program and Abstracts. Washington, DC: The Endocrine Society Press; 1995:322. Abstract P2-127.
42. Uyanik BS, Ari Z, Gumus B, Yigitoglu MR, Arslan T. Beneficial effects of testosterone on the lipoprotein profile in healthy elderly men: a placebo controlled study. Jpn Heart J. 1997;38:73-82.
43. Møller J. Cholesterol: Interactions With Testosterone and Cortisol in Cardiovascular Disease. Berlin, Germany: Springer-Verlag; 1987.
44. Carruthers M. Male Menopause: Restoring Vitality and Virility. New York: HarperCollins Publishers; 1996.
45. Bonnell RW, Pritchett CP, Rardin TE. Treatment of angina pectoris and coronary artery disease with sex hormones. Ohio State Med J. 1941;37: 554-556.
46. Lesser MA. The treatment of angina pectoris with testosterone propionate. N Engl J Med. 1942;226:51-54.
47. Wu S, Weng X. Therapeutic effects of an androgenic preparation on myocardial ischemia and cardiac function in 62 elderly male coronary heart disease patients. Chin Med J. 1993;106:415-418.
48. Bruck B, Brehme U, Gugel N, Hanke S, Finking G, Lutz C, Benda N, Schmahl FW, Haasis R, Hanke H. Gender-specific differences in the effects of testosterone and estrogen on the development of atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1997;17:2192-2199.
49. Black LJ, Sato M, Rowly ER, Magee DE, Dekele A, Williams DC, Cullinan GJ, Bendele R, Kaufman RF, Bensch WR, Frolik Ca, Termine JD, Bryant HU. Raloxifene (LY139481 HCl) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest. 1994;93:63-69.
50. Draper MW, Flowers DE, Huster WJ, Neild JA, Harper KD, Araud C. A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res. 1996;11:835-842.